- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06671288
"Effects of Balloon-blowing Exercises With Abdominal & Lumbar Core Muscle Activation Position Among Smokers"
The principle function of the lungs is the facilitation of the gaseous exchange, commonly referred as respiratory or breathing. Cigarette smoking has detrimental effects on nearly every organ in the body, leading to a higher incidence of diseases and contributing to a gradual deterioration of the smoker's health.Cigarette smoking has detrimental effects on nearly every organ in the body, leading to a higher incidence of diseases and contributing to a gradual deterioration of the smoker's health.
Cigarette smoking is linked to mild airway obstruction and a deceleration in the growth of lung function.Performing balloon-blowing exercises with abdominal and lumbar core muscles activation position leads to an improvement on pulmonary function and quality of life in smokers.
Study Overview
Status
Conditions
Detailed Description
Cigarette smoking has detrimental effects on nearly every organ in the body, leading to a higher incidence of diseases and contributing to a gradual deterioration of the smoker's health, including a progressive impairment of lung function. Cigarette smoking is linked to mild airway obstruction and a deceleration in the growth of lung function.
Smokers may experience inflammation and narrowing of their airways, resulting in increased resistance to the outward flow of air during exhalation. This restriction in airflow can negatively impact respiratory parameters, exercise tolerance, and overall quality of life.
Performing balloon-blowing exercises with abdominal and lumbar core muscles activation position leads to an improvement on pulmonary function and quality of life in smokers.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tooba Shahbaz, MS-CPT*
- Phone Number: 0340-5416747
- Email: tshahbaz59@gmail.com
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 46000
- Recruiting
- Foundation University College of Physical Therapy
-
Contact:
- Sana Bashir, PhD*
- Phone Number: 0321-8529475
- Email: sana.bashir65@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults: aged (25-59 years)
- Gender: Both males and females
- Grade1- Grade 4 on Modified MRC dyspnea scale
- COPD classes (mild, moderate ) according to GOLD COPD Guidelines
- Participating voluntarily and follow the instructions & performing
The number of packs of cigarettes smoked per day by the number of years the person has smoked.
- pack yr = 20 cig/day x 1 yrs
- pack yr = 20 cig/day x 2 yrs
Exclusion criteria:
- Severe cases of obstruction like Severe asthma & status asthmaticus, Severe COPD, bullous emphysema for pneumothorax.
- Any congenital deformities of chest wall, Demonstrated neuromuscular or neurological deficit/disease of chest wall
- Other serious Cardiopulmonary diseases including pulmonary embolism, pulmonary ----Hypertension, Active TB, pneumonias or other acute illnesses
- Any recent cardiothoracic or abdominal surgery, trauma or injury
- Pregnancy
- Any psychiatric illnesses
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interventional group
Patients in this group will receive balloon -blowing exercise with abdominal & lumbar core muscle activation position Total 4 weeks protocol.
Three sessions per week will be supervised by physical therapist.
|
Patients in this group will recieve Balloon-blowing exercises with abdominal and lumbar core muscles activation position Total 4 weeks protocol will be followed in which 3 sessions per week will be supervised by physical therapist. FREQUENCY: 3 times a week, INTENSITY : Moderate, TIME: 4 sets of balloon-blowing with 1 min rest (30 mins) TYPE: Balloon-blowing with abdominal & lumbar core muscle activation position, DURATION : 4 weeks |
|
Active Comparator: Control group
Patients will receive diaphragmatic breathing exercises. Total 4 weeks protocol. Before and after 4 weeks pre and post interventional values will be taken. |
Participants in this group will only be receiving diaphragmatic breathing exercise for 4 weeks.
FREQUENCY: 3 times a week , INTENSITY: Moderate, TIME: 4 sets of diaphragmatic breathing with 1 min rest, TYPE: Diaphragmatic breathing, DURATION: 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FVC (forced vital capacity):
Time Frame: 4 weeks
|
FVC (forced vital capacity): The amount of air that can be maximum forcefully be exhaled after taking deep breath.
|
4 weeks
|
|
FEV1
Time Frame: 4 weeks
|
FEV1(Forced expiratory volume in 1 second): The volume of air that is forcefully exhaled in one second.
|
4 weeks
|
|
FEV1/FVC
Time Frame: 4 weeks
|
FEV1/FVC: The ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs.
|
4 weeks
|
|
PEF (Peak expiratory flow)
Time Frame: 4 Weeks
|
PEF( Peak expiratory flow): Measurement of the highest speed at which a individual can exhale air from their lungs after a full inhalation.
|
4 Weeks
|
|
Dyspnea
Time Frame: 4 Weeks
|
Evaluation will be done using mMRC dyspnea scale (0-4). 0 I only get breathless with strenuous exercise
|
4 Weeks
|
|
Quality of life of participant
Time Frame: 4 weeks
|
Quality of life questionnaire (SF-36) will be used to evaluate smokers QOLSF-36 Questionnaire (0-100). Each question carries equal weight the lower the score the more the disability. The higher the score the lesser the disability. 0: Maximum disability 100: No disability |
4 weeks
|
|
Oxygen saturation
Time Frame: 4 weeks
|
Pulse oximeter will be used to measure oxygen saturation
|
4 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FUI/CTR/2024/27
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.